Abstract
We have developed synthetic double-stranded oligodeoxynucleotides (ODN) as ‘decoy’ cis elements that block the binding of nuclear factors to promoter regions of targeted genes, resulting in the inhibition of gene transactivation in vivo. In the present study, we employed decoy ODN targeting the transcription factor nuclear factor-kappaB (NF-kappaB) binding cis-elements to hepatic metastasis of murine reticulosarcoma M5076 in mice. Intravenous inoculation of M5076 into mice caused a marked increase in gene expression of interleukin-1β, tumor necrosis factor-α and intercellular adhesion molecule-1 in the liver, whereas intravenous treatment with NF-kappaB decoy ODN reduced M5076-induced transactivation of these genes. Treatment with NF-kappaB decoy ODN, but not scrambled decoy ODN, significantly inhibited hepatic metastasis of M5076 in mice, and furthermore the combined treatment of NF-kappaB decoy ODN with an anti-cancer drug resulted in complete inhibition of hepatic metastasis in half of the mice, without affecting myelosuppression induced by the anti-cancer drug. Here, NF-kappaB decoy ODN inhibited hepatic metastasis of M5076 in mice possibly through a decrease in transactivation of important NF-kappaB-driven genes and also potentiated the anti-metastatic effect of an anti-cancer drug, demonstrating the first successful in vivo therapy for cancer metastasis using NF-kappaB decoy ODN as a novel molecular decoy approach.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fidler IJ . Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes Memorial Award Lecture Cancer Res 1990 50: 6130–6138
Talmadge JE . The selective nature of metastasis Cancer Metast Rev 1983 2: 25–40
Weiss L, Ward PM . Cell detachment and metastasis Cancer Metast Rev 1983 2: 111–127
Liotta LA . Tumor invasion and metastasis. Role of the extracellular matrix: Rhoads Memorial Award Lecture Cancer Res 1986 46: 1–7
Nicolson GL . Cancer metastasis: organ colonization and the cell-surface properties of malignant cells Biochim Biophys Acta 1982 695: 113–176
Weiss L, Orr FW, Honn KV . Interactions of cancer cells with the microvasculature during metastasis FASEB J 1988 2: 12–21
Rice GE, Bevilacqua MP . An inducible endothelial cell surface glycoprotein mediates melanoma adhesion Science 1989 246: 1303–1306
Albelda SM . Role of integrins and other cell adhesion molecules in tumor progression and metastasis Lab Invest 1993 68: 4–17
Okahara H, Yagita H, Miyake K, Okumura K . Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor α enhancement of experimental metastasis Cancer Res 1994 54: 3233–3236
Glinsky GV . Anti-adhesion cancer therapy Cancer Metast Rev 1998 17: 177–185
Bani MR, Garofalo A, Scanziani E, Giavazzi R . Effect of interleukin-1-beta on metastasis formation in different tumor systems J Natl Cancer Inst 1991 83: 119–123
Butcher EC . Warner-Lambert/Parke-Davis Award lecture. Cellular and molecular mechanisms that direct leukocyte traffic Am J Pathol 1990 136: 3–11
Cotran RS . American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity Am J Pathol 1987 129: 407–413
Stoolman LM . Adhesion molecules controlling lymphocyte migration Cell 1989 56: 907–910
Lenardo MJ, Baltimore D . NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control Cell 1989 58: 227–229
Neish AS et al. Functional analysis of the human vascular cell adhesion molecule 1 promoter J Exp Med 1992 176: 1583–1593
Brennan DC, Jevnika AM, Takei F, Reubin-Kelley VE . Mesangial cell accessory functions: mediation by intercellular adhesion molecule-1 Kidney Int 1990 38: 1039–1046
Bielinska A, Shivdasani RA, Zhang LQ, Nabel GJ . Regulation of gene expression with double-stranded phosphorothioate oligonucleotides Science 1990 250: 997–1000
Morishita R, Higaki J, Tomita N, Ogihara T . Application of transcription factor ‘decoy’ strategy as means of gene therapy and study of gene expression in cardiovascular disease Circ Res 1998 82: 1023–1028
Yamada T et al. In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer J Clin Invest 1995 96: 1230–1237
Morishita R et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo Proc Natl Acad Sci USA 1995 92: 5855–5859
Morishita R et al. In vivo transfection of cis element ‘decoy’ against nuclear factor-kB binding site prevents myocardial infarction Nature Med 1997 3: 894–899
Kawamura I et al. Intratumoral injection of oligonucleotides to the NFkB binding site inhibits cachexia in a mouse tumor model Gene Therapy 1999 6: 91–97
Talmadge JE, Key ME, Hart IR . Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin Cancer Res 1981 41: 1271–1280
Hart IR, Talmadge JE, Fidler IJ . Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth Cancer Res 1981 41: 1281–1287
Yamaoka M et al. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor o-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470) Cancer Res 1993 53: 4262–4267
Xie K et al. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362 Cancer Res 1995 55: 3123–3131
Higgins KA et al. Antisense inhibition of the p65 subunit of NF-kB blocks tumorigenicity and causes tumor regression Proc Natl Acad Sci USA 1993 90: 9901–9905
Bours V et al. The NF-kB transcription factor and cancer: high expression of NF-kB- and IkB-related proteins in tumor cell lines Biochem Pharmacol 1994 47: 145–149
Tozawa K, Sakurada S, Kohri K, Okamoto T . Effects of anti-nuclear factor kB reagents in blocking adhesion of human cancer cells to vascular endothelial cells Cancer Res 1995 55: 4162–4167
La Porta CAM, Comolli R . PKC-dependent modulation of IkBα-NFkB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells Anticancer Res 1998 18: 2591–2597
Hinz M et al. NF-kB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition Mol Cell Biol 1999 19: 2690–2698
Siebenlist U, Franzoso G, Brown K . Structure, regulation and function of NF-kB Annu Rev Cell Biol 1994 10: 405–455
Wulczyn FG, Krappmann D, Scheidereit C . The NF-kB/Rel and IkB gene families: mediators of immune response and inflammation J Mol Med 1996 74: 749–769
Kittelberger R, Davis PF, Stehbens WE . An improved immunofluorescence technique for the histological examination of blood vessel tissue Acta Histochem 1989 86: 137–142
Morishita R et al. Pharmacokinetics of antisense oligonucleotides (cyclin B1 and cdc 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery Gene 1994 149: 13–19
Aoki M et al. In vivo transfer efficiency of antisense oligonucleotides into the myocardium using HVJ-liposome method Biochem Biophys Res Commun 1997 231: 540–545
Kaneda Y, Iwai K, Uchida T . Increased expression of DNA cointroduced with nuclear protein in adult rat liver Science 1989 243: 375–378
Suzuki J et al. Prevention of graft coronary arteriosclerosis by antisense cdk 2 kinase oligonucleotide Nature Med 1997 3: 900–903
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kawamura, I., Morishita, R., Tsujimoto, S. et al. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Gene Ther 8, 905–912 (2001). https://doi.org/10.1038/sj.gt.3301478
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301478
Keywords
This article is cited by
-
Transcription factor decoy against stem cells master regulators, Nanog and Oct-4: a possible approach for differentiation therapy
Tumor Biology (2015)
-
Icariin Enhances Radiosensitivity of Colorectal Cancer Cells by Suppressing NF-κB Activity
Cell Biochemistry and Biophysics (2014)
-
Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma
Cancer Gene Therapy (2011)
-
In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity
Gene Therapy (2004)
-
Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model
Gene Therapy (2002)